291.76
price down icon0.39%   -1.13
 
loading
Schlusskurs vom Vortag:
$292.89
Offen:
$292.89
24-Stunden-Volumen:
1.38M
Relative Volume:
0.62
Marktkapitalisierung:
$157.07B
Einnahmen:
$34.76B
Nettoeinkommen (Verlust:
$6.62B
KGV:
23.87
EPS:
12.223
Netto-Cashflow:
$10.61B
1W Leistung:
-2.36%
1M Leistung:
+4.49%
6M Leistung:
+4.26%
1J Leistung:
-7.58%
1-Tages-Spanne:
Value
$290.66
$293.94
1-Wochen-Bereich:
Value
$290.66
$303.85
52-Wochen-Spanne:
Value
$253.30
$335.88

Amgen Inc Stock (AMGN) Company Profile

Name
Firmenname
Amgen Inc
Name
Telefon
(805)447-1000
Name
Adresse
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Name
Mitarbeiter
28,000
Name
Twitter
@amgen
Name
Nächster Verdiensttermin
2025-02-04
Name
Neueste SEC-Einreichungen
Name
AMGN's Discussions on Twitter

Vergleichen Sie AMGN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - General icon
AMGN
Amgen Inc
291.76 157.68B 34.76B 6.62B 10.61B 12.22
Drug Manufacturers - General icon
LLY
Lilly Eli Co
825.45 736.03B 53.26B 13.80B -50.20M 15.08
Drug Manufacturers - General icon
JNJ
Johnson Johnson
190.40 463.72B 92.15B 25.12B 20.46B 10.36
Drug Manufacturers - General icon
ABBV
Abbvie Inc
227.99 403.22B 58.33B 3.73B 18.24B 2.1013
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
130.36 254.84B 53.40B 13.68B 16.89B 6.8864
Drug Manufacturers - General icon
MRK
Merck Co Inc
87.49 217.76B 63.43B 16.42B 14.72B 6.4861

Amgen Inc Stock (AMGN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-09-03 Fortgesetzt Raymond James Mkt Perform
2025-05-20 Fortgesetzt Guggenheim Neutral
2025-04-22 Fortgesetzt Cantor Fitzgerald Neutral
2024-12-10 Fortgesetzt BofA Securities Underperform
2024-11-15 Eingeleitet Wolfe Research Peer Perform
2024-11-14 Eingeleitet Citigroup Neutral
2024-10-17 Eingeleitet Bernstein Outperform
2024-10-14 Herabstufung Truist Buy → Hold
2024-09-27 Eingeleitet Cantor Fitzgerald Overweight
2024-08-07 Herabstufung Wells Fargo Overweight → Equal Weight
2024-05-03 Hochstufung Barclays Underweight → Equal Weight
2024-05-03 Hochstufung William Blair Mkt Perform → Outperform
2024-03-28 Fortgesetzt Raymond James Mkt Perform
2024-02-07 Herabstufung Leerink Partners Outperform → Market Perform
2023-12-21 Hochstufung Daiwa Securities Neutral → Buy
2023-12-19 Hochstufung BMO Capital Markets Market Perform → Outperform
2023-12-12 Hochstufung RBC Capital Mkts Sector Perform → Outperform
2023-11-09 Eingeleitet Deutsche Bank Hold
2023-11-02 Hochstufung Truist Hold → Buy
2023-10-20 Fortgesetzt JP Morgan Neutral
2023-10-17 Fortgesetzt Morgan Stanley Equal-Weight
2023-10-11 Fortgesetzt BofA Securities Neutral
2023-09-06 Eingeleitet HSBC Securities Buy
2023-04-24 Bestätigt Oppenheimer Outperform
2023-03-13 Hochstufung Wells Fargo Equal Weight → Overweight
2023-02-13 Bestätigt Truist Buy
2022-11-18 Eingeleitet Credit Suisse Underperform
2022-10-31 Herabstufung Barclays Equal Weight → Underweight
2022-10-11 Hochstufung Morgan Stanley Equal-Weight → Overweight
2022-05-23 Eingeleitet SVB Leerink Mkt Perform
2022-02-09 Bestätigt Barclays Equal Weight
2022-02-09 Bestätigt Jefferies Buy
2022-02-09 Bestätigt Morgan Stanley Equal-Weight
2022-02-09 Bestätigt Oppenheimer Outperform
2022-02-09 Bestätigt Wells Fargo Equal Weight
2022-01-05 Herabstufung BofA Securities Buy → Neutral
2021-12-09 Fortgesetzt Wells Fargo Equal Weight
2021-12-06 Eingeleitet Goldman Buy
2021-11-19 Eingeleitet BMO Capital Markets Market Perform
2021-09-23 Herabstufung Daiwa Securities Outperform → Neutral
2021-09-07 Herabstufung Morgan Stanley Overweight → Equal-Weight
2020-12-29 Eingeleitet Daiwa Securities Buy
2020-10-28 Eingeleitet UBS Neutral
2020-10-26 Hochstufung Raymond James Mkt Perform → Outperform
2020-10-12 Hochstufung Truist Hold → Buy
2020-10-09 Herabstufung Bernstein Outperform → Mkt Perform
2020-10-09 Herabstufung Truist Buy → Hold
2020-10-08 Herabstufung Raymond James Outperform → Mkt Perform
2020-04-15 Fortgesetzt Guggenheim Neutral
2020-03-31 Eingeleitet Wolfe Research Peer Perform
2020-03-30 Hochstufung Raymond James Mkt Perform → Outperform
2020-03-05 Hochstufung BofA/Merrill Neutral → Buy
2020-02-27 Eingeleitet Barclays Equal Weight
2020-01-31 Herabstufung Robert W. Baird Neutral → Underperform
2020-01-21 Hochstufung Evercore ISI In-line → Outperform
2019-12-24 Eingeleitet Raymond James Mkt Perform
2019-12-17 Fortgesetzt Morgan Stanley Overweight
2019-11-12 Eingeleitet SunTrust Buy
2019-11-05 Hochstufung Cantor Fitzgerald Neutral → Overweight
2019-10-17 Fortgesetzt BofA/Merrill Neutral
2019-08-19 Herabstufung Mizuho Buy → Neutral
2019-05-23 Hochstufung Citigroup Neutral → Buy
Alle ansehen

Amgen Inc Aktie (AMGN) Neueste Nachrichten

pulisher
Oct 25, 2025

What dividend safety score for Amgen Inc. stockMarket Volume Report & Weekly Chart Analysis and Trade Guides - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Why global investors buy Amgen Inc. (AMG0) stockEntry Point & Expert Curated Trade Setup Alerts - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

What is the fair value estimate for Amgen Inc. (AMG) stock in 2025July 2025 Market Mood & Real-Time Chart Pattern Alerts - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Amgen's (AMGN) "Buy (B-)" Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 25, 2025
pulisher
Oct 25, 2025

Will Amgen Inc. (AMG0) stock extend growth storyGap Up & Breakout Confirmation Trade Signals - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Will Amgen Inc. (AMG0) stock recover faster than industry2025 Momentum Check & Fast Moving Stock Watchlists - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Amgen, Inc. Experiences Revision in Its Stock Evaluation Amid Market Dynamics - Markets Mojo

Oct 25, 2025
pulisher
Oct 25, 2025

Will Amgen Inc. (AMG0) stock profit from AI boomQuarterly Profit Report & Free Technical Confirmation Trade Alerts - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Why global investors buy Amgen Inc. (AMG) stock2025 Technical Patterns & Stepwise Entry/Exit Trade Alerts - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

UBS Raises PT on Amgen Inc. (AMGN) to $326 From $315, Keeps a Neutral Rating - MSN

Oct 25, 2025
pulisher
Oct 25, 2025

Amgen Inc. stock daily chart insightsMarket Activity Report & Risk Controlled Daily Trade Plans - newser.com

Oct 25, 2025
pulisher
Oct 24, 2025

Will Amgen Inc. (AMG0) stock outperform energy sector in 2025Trade Risk Summary & Technical Buy Zone Confirmations - newser.com

Oct 24, 2025
pulisher
Oct 24, 2025

Should I buy Amgen Inc. (AMG0) stock before earnings seasonTreasury Yields & AI Enhanced Market Trend Forecasts - newser.com

Oct 24, 2025
pulisher
Oct 24, 2025

Biogen Takes Aim At Amgen’s Tavneos With Vanqua Licensing Pact - Citeline News & Insights

Oct 24, 2025
pulisher
Oct 24, 2025

The Zacks Analyst Blog Highlights Amazon.com, Wells Fargo, Amgen, IDT and Village Super Market - Zacks Investment Research

Oct 24, 2025
pulisher
Oct 24, 2025

Sumitomo Mitsui Trust Group Inc. Has $475.22 Million Holdings in Amgen Inc. $AMGN - MarketBeat

Oct 24, 2025
pulisher
Oct 24, 2025

ESMO 25: What Was Behind Bemarituzumab’s Waning Efficacy In FORTITUDE-101? - Citeline News & Insights

Oct 24, 2025
pulisher
Oct 24, 2025

Moloney Securities Asset Management LLC Sells 2,270 Shares of Amgen Inc. $AMGN - MarketBeat

Oct 24, 2025
pulisher
Oct 24, 2025

Sector Gamma AS Reduces Stock Position in Amgen Inc. $AMGN - MarketBeat

Oct 24, 2025
pulisher
Oct 24, 2025

Asset Management One Co. Ltd. Boosts Stock Holdings in Amgen Inc. $AMGN - MarketBeat

Oct 24, 2025
pulisher
Oct 24, 2025

FSM Wealth Advisors LLC Invests $440,000 in Amgen Inc. $AMGN - MarketBeat

Oct 24, 2025
pulisher
Oct 24, 2025

First Citizens Bank & Trust Co. Raises Stake in Amgen Inc. $AMGN - MarketBeat

Oct 24, 2025
pulisher
Oct 24, 2025

Strategic Blueprint LLC Raises Stock Holdings in Amgen Inc. $AMGN - MarketBeat

Oct 24, 2025
pulisher
Oct 24, 2025

Rep. Lisa C. McClain Sells Off Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Oct 24, 2025
pulisher
Oct 23, 2025

Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know - sharewise.com

Oct 23, 2025
pulisher
Oct 23, 2025

Top Research Reports for Amazon.com, Wells Fargo & Amgen - Yahoo Finance

Oct 23, 2025
pulisher
Oct 23, 2025

Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Has $16.73 Million Stake in Amgen Inc. $AMGN - MarketBeat

Oct 23, 2025
pulisher
Oct 23, 2025

Paralel Advisors LLC Purchases New Shares in Amgen Inc. $AMGN - MarketBeat

Oct 23, 2025
pulisher
Oct 23, 2025

Bleakley Financial Group LLC Increases Stock Position in Amgen Inc. $AMGN - MarketBeat

Oct 23, 2025
pulisher
Oct 23, 2025

Principle Wealth Partners LLC Lowers Stock Position in Amgen Inc. $AMGN - MarketBeat

Oct 23, 2025
pulisher
Oct 23, 2025

Exencial Wealth Advisors LLC Decreases Position in Amgen Inc. $AMGN - MarketBeat

Oct 23, 2025
pulisher
Oct 23, 2025

Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices - The New York Times

Oct 23, 2025
pulisher
Oct 22, 2025

Halper Sadeh LLC Encourages Amgen Inc. Shareholders to Contact the Firm to Discuss Their Rights - The AI Journal

Oct 22, 2025
pulisher
Oct 22, 2025

Amgen Inc. $AMGN Shares Purchased by Greatmark Investment Partners Inc. - MarketBeat

Oct 22, 2025
pulisher
Oct 22, 2025

Ethic Inc. Boosts Position in Amgen Inc. $AMGN - MarketBeat

Oct 22, 2025
pulisher
Oct 22, 2025

Amgen Abandons Patent For Way Of Boosting Drug Potency - Law360

Oct 22, 2025
pulisher
Oct 22, 2025

Amgen Inc. $AMGN Shares Sold by ARK Investment Management LLC - MarketBeat

Oct 22, 2025
pulisher
Oct 22, 2025

Amgen Inc. $AMGN Shares Bought by Parcion Private Wealth LLC - MarketBeat

Oct 22, 2025
pulisher
Oct 22, 2025

AstraZeneca and Amgen’s Tezspire approved in EU for nasal polyps - Investing.com

Oct 22, 2025
pulisher
Oct 22, 2025

Brookstone Capital Management Increases Stock Position in Amgen Inc. $AMGN - MarketBeat

Oct 22, 2025
pulisher
Oct 22, 2025

Pacific Heights Asset Management LLC Boosts Holdings in Amgen Inc. $AMGN - MarketBeat

Oct 22, 2025
pulisher
Oct 22, 2025

OMC Financial Services LTD Boosts Stock Holdings in Amgen Inc. $AMGN - MarketBeat

Oct 22, 2025
pulisher
Oct 22, 2025

Amgen Inc. $AMGN Shares Acquired by D.A. Davidson & CO. - MarketBeat

Oct 22, 2025
pulisher
Oct 22, 2025

Avidian Wealth Enterprises LLC Increases Stake in Amgen Inc. $AMGN - MarketBeat

Oct 22, 2025
pulisher
Oct 22, 2025

AstraZeneca, Amgen's Severe Chronic Rhinosinusitis Drug Secures EU Approval - MarketScreener

Oct 22, 2025
pulisher
Oct 22, 2025

Using flow based indicators on Amgen Inc.Rate Cut & Low Drawdown Momentum Trade Ideas - newser.com

Oct 22, 2025
pulisher
Oct 22, 2025

Will Amgen Inc. (AMG0) stock benefit from mergersPortfolio Update Report & Growth Oriented Trading Recommendations - newser.com

Oct 22, 2025

Finanzdaten der Amgen Inc-Aktie (AMGN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$120.94
price up icon 0.17%
drug_manufacturers_general PFE
$24.76
price up icon 0.36%
drug_manufacturers_general NVO
$52.96
price down icon 0.51%
drug_manufacturers_general SNY
$51.64
price up icon 4.28%
drug_manufacturers_general MRK
$87.49
price up icon 0.36%
Kapitalisierung:     |  Volumen (24h):